-
Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors.
Author: Peng Y1, Li Q1, Zhang J1, Shen W1, Zhang X1, Sun C1, Cui H2.
Journal: Biosci Trends. 2019 Jan 22;12(6):537-552. doi: 10.5582/bst.2018.01246. Epub 2018 Dec 17.
-
Circular RNA profiling reveals circRNA1656 as a novel biomarker in high grade serous ovarian cancer.
Author: Gao Y1,2, Zhang C1, Liu Y1, Wang M1.
Journal: Biosci Trends. 2019 May 12;13(2):204-211. doi: 10.5582/bst.2019.01021. Epub 2019 Apr 24.
-
Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
Author: Luo H1, Li C2, Chen L2.
Journal: Biosci Trends. 2019 May 12;13(2):176-181. doi: 10.5582/bst.2019.01088. Epub 2019 Apr 27.
-
Effect of Shufeng Jiedu capsules as a broad-spectrum antibacterial.
Author: Bao Y, Gao Y, Cui X.
Journal: Biosci Trends. 2016 Feb;10(1):74-8. doi: 10.5582/bst.2015.01172. Epub 2016 Feb 15.
-
Control of antibiotic resistance in China must not be delayed: The current state of resistance and policy suggestions for the government, medical facilities, and patients.
Author: Tang Q, Song P, Li J, Kong F, Sun L, Xu L.
Journal: Biosci Trends. 2016 Feb;10(1):1-6. doi: 10.5582/bst.2016.01034.
-
Atypical pathogen infection in community-acquired pneumonia.
Author: Yu Y, Fei A.
Journal: Biosci Trends. 2016 Feb;10(1):7-13. doi: 10.5582/bst.2016.01021.
-
Workload, burnout, and medical mistakes among physicians in China: A cross-sectional study.
Author: Wen J, Cheng Y, Hu X, Yuan P, Hao T, Shi Y.
Journal: Biosci Trends. 2016 Feb;10(1):27-33. doi: 10.5582/bst.2015.01175.
-
The current management of cholangiocarcinoma: A comparison of current guidelines.
Author: Cai Y, Cheng N, Ye H, Li F, Song P, Tang W.
Journal: Biosci Trends. 2016 May 23;10(2):92-102. doi: 10.5582/bst.2016.01048. Epub 2016 Mar 29.
